BC-819/PEI

BIOLOGICAL2 trials

Sponsors

Anchiano Therapeutics Israel Ltd.

Conditions

Superficial Bladder CancerTransitional Cell Carcinoma of Bladder

Phase 1

Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma

CompletedNCT01878188

Anchiano Therapeutics Israel Ltd.Transitional Cell Carcinoma of Bladder

Start: 2013-02-28End: 2017-10-31Updated: 2019-03-11

Phase 2

Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer

CompletedNCT00595088

Anchiano Therapeutics Israel Ltd.Superficial Bladder Cancer

Start: 2008-01-31End: 2013-01-31Updated: 2019-04-30

Related Papers

Phase II trial of BC-819 intravesical gene therapy in combination with BCG in patients with non-muscle invasive bladder cancer (NMIBC).

Journal of Clinical Oncology2018-02-2015 citations